Literature DB >> 3791693

Role of antigenic charge and antibody avidity on the glomerular immune complex localization in serum sickness of mice.

A Koyama, H Inage, M Kobayashi, Y Ohta, M Narita, S Tojo, J S Cameron.   

Abstract

Passive injection of mice with preformed immune complexes (IC) made from cationized bovine serum albumin (BSA) and anti-native BSA antibody gave immune deposits along the glomerular capillary walls at predominantly subepithelial sites, while similar quantities of complexes made with native, anionized BSA did not deposit. Peripheral localization could be obtained also using low avidity antibody and a great excess of native BSA. Ultracentrifugation analysis showed that the size of IC in the animals given complexes containing cationized BSA was a little larger than 7 S, whereas those formed with the native or anionized BSA were around 19 S. The anti-native BSA antibody had a low avidity for cationized BSA in vitro, and thus all the IC which could deposit peripheral capillary walls were small and contained low avidity antibody. Chemical cationization of BSA alters the precipitability of the antibody and also the size and stability of the complexes formed. In an active model, injection of cationized BSA into mice preimmunized with cationized BSA caused localization of the BSA and its antibody in the peripheral capillary walls. Analysis of the circulating IC formed in this model also revealed low avidity of antibody and small-sized IC. From these results, it is clear that chemical cationization of antigen changes the characteristics of the antigen-antibody interaction, e.g. low precipitating efficiency and the formation of small-sized IC. Therefore, in addition to interaction of cationized IC with the polyanion layer of the glomerular basement membrane (GBM), the properties of antigen-antibody interaction play an important role in the deposition of IC along the peripheral capillary walls in a model of membranous glomerulonephritis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3791693      PMCID: PMC1542446     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  17 in total

1.  Modified bovine serum albumin. VII. Studies on the role of free carboxyl groups of the protein in the interaction with its antibodies.

Authors:  J SRI RAM; P H MAURER
Journal:  Arch Biochem Biophys       Date:  1959-07       Impact factor: 4.013

2.  Experimental glomerulonephritis in the rat induced by antibodies directed against tubular antigens. V. Fixed glomerular antigens in the pathogenesis of heterologous immune complex glomerulonephritis.

Authors:  B J Van Damme; G J Fleuren; W W Bakker; R L Vernier; P J Hoedemaeker
Journal:  Lab Invest       Date:  1978-04       Impact factor: 5.662

3.  Immune complex disease. V. The nature of the circulating complexes associated with glomerular alterations in the chronic BSA-rabbit system.

Authors:  F G Germuth; L B Senterfit; G R Dreesman
Journal:  Johns Hopkins Med J       Date:  1972-06

4.  In situ immune complex formation and glomerular injury.

Authors:  W G Couser; D J Salant
Journal:  Kidney Int       Date:  1980-01       Impact factor: 10.612

5.  A method for the quantitative modification and estimation of carboxylic acid groups in proteins.

Authors:  D G Hoare; D E Koshland
Journal:  J Biol Chem       Date:  1967-05-25       Impact factor: 5.157

6.  Experimental glomerulonephritis in the isolated perfused rat kidney.

Authors:  W G Couser; D R Steinmuller; M M Stilmant; D J Salant; L M Lowenstein
Journal:  J Clin Invest       Date:  1978-12       Impact factor: 14.808

7.  Passive immune complex glomerulonephritis in mice: models for various lesions found in human disease. II. Low avidity complexes and diffuse proliferative glomerulonephritis with subepithelial deposits.

Authors:  F G Germuth; E Rodriguez; C A Lorelle; E I Trump; L L Milano; O Wise
Journal:  Lab Invest       Date:  1979-10       Impact factor: 5.662

8.  Experimental glomerulonephritis in the rat induced by antibodies directed against tubular antigens. IV. Investigations into the pathogenesis of the model.

Authors:  G J Fleuren; R vd Lee; H A Greben; B J Van Damme; P J Hoedemaeker
Journal:  Lab Invest       Date:  1978-04       Impact factor: 5.662

9.  Experimental glomerulonephritis. The pathogenesis of a laboratory model resembling the spectrum of human glomerulonephritis.

Authors:  F J DIXON; J D FELDMAN; J J VAZQUEZ
Journal:  J Exp Med       Date:  1961-05-01       Impact factor: 14.307

10.  Quantitative studies of in situ immune complex glomerulonephritis in the rat induced by planted, cationized antigen.

Authors:  T Oite; S R Batsford; M J Mihatsch; H Takamiya; A Vogt
Journal:  J Exp Med       Date:  1982-02-01       Impact factor: 14.307

View more
  6 in total

Review 1.  Pathogenesis of membranous nephropathy: recent advances and future challenges.

Authors:  Pierre Ronco; Hanna Debiec
Journal:  Nat Rev Nephrol       Date:  2012-02-28       Impact factor: 28.314

Review 2.  Immunopathogenesis of membranous nephropathy: an update.

Authors:  Hanna Debiec; Pierre Ronco
Journal:  Semin Immunopathol       Date:  2014-04-09       Impact factor: 9.623

3.  Detection of DNA-bound immunoglobulins in patients with lupus nephritis, using monoclonal anti-DNA antibody.

Authors:  A Koyama; M Kobayashi; S Suzuki; M Suzuki; N Yamaguchi; M Narita
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

4.  Low antibody affinity restricted to the IgA isotype in IgA nephropathy.

Authors:  L Layward; A C Allen; J M Hattersley; S J Harper; J Feehally
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

5.  Effect of cyclosporin on immune complex deposition in murine glomerulonephritis.

Authors:  D G Quinn; J S Fennell; O Sheils; E F Gaffney; C F Feighery
Journal:  Immunology       Date:  1991-04       Impact factor: 7.397

6.  Secondary membranous glomerulonephritis associated with recipient residual lymphoma cells after allogeneic bone marrow transplantation.

Authors:  Kentaro Sakai; Joichi Usui; Hirayasu Kai; Masahiro Hagiwara; Naoki Morito; Chie Saito; Keigyou Yoh; Syuichi Tsuruoka; Kouichi Hirayama; Kumi Aita; Michio Nagata; Kunihiro Yamagata
Journal:  Clin Exp Nephrol       Date:  2008-12-26       Impact factor: 2.801

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.